General Catalyst is a global investment and transformation company that partners with the world’s most ambitious entrepreneurs to drive resilience and applied AI.
Artificial Intelligence 25%Health Care 21%Software 15%Seed–A
Portfolio sectors
Artificial Intelligence 25%Health Care 21%Software 15%Financial Services 12%Cybersecurity 7%
Latest money in the portfolio
More about the fund
57 exitsnamed in 14 roundsmedian round $48.3M197 companies growing
Most often together with
GV
Leads rounds · 1 in 12 mo
In 2008, Google's founders asked, "What would it look like to create a radically different kind of venture fund?" It would need to have the reliability of a single LP, the autonomy of a traditional VC, and the technical expertise of a founder.
Artificial Intelligence 26%Health Care 24%Software 14%Series A–B
Latest money: Ramp $1.9B · Oct 15
· 15 more rounds in 90 days
Portfolio sectors
Artificial Intelligence 26%Health Care 24%Software 14%Biotechnology 10%Cybersecurity 9%
Latest money in the portfolio
More about the fund
217 exitsnamed in 2 roundsmedian round $65.1M146 companies growing
Most often together with
Albion
Leads rounds · 3 in 12 mo
AlbionVC is a London-based venture capital firm that invests in fast-growing B2B software and healthcare technology companies. It manages several of the UK's established venture capital trusts alongside institutional funds, backing businesses from early stage through to growth rounds. The firm, formerly known as Albion Capital, was established in 1996 and is headquartered in London.
Artificial Intelligence 30%Health Care 21%Financial Services 17%Seed–A
Latest money: 5Mins.ai · Oct 7
· 14 more rounds in 90 days
Portfolio sectors
Artificial Intelligence 30%Health Care 21%Financial Services 17%Software 8%Cybersecurity 8%
Latest money in the portfolio
More about the fund
8 exitsnamed in 3 roundsmedian round $12M9 companies growing
Most often together with
Health Care 30%Artificial Intelligence 16%Hardware 15%SeedUnited Kingdom
Latest money: mintneuro · Oct 1
· 14 more rounds in 90 days
Portfolio sectors
Health Care 30%Artificial Intelligence 16%Hardware 15%Science & Engineering 12%Energy & Utilities 11%
Latest money in the portfolio
More about the fund
4 exitsmedian round $18.4M6 companies growing
Most often together with
Khosla Ventures is a venture capital firm that makes early-stage bets on bold, science and technology-driven companies. It invests in artificial intelligence, sustainability and clean energy, healthcare, robotics, food and enterprise technology, with notable holdings including OpenAI and Impossible Foods. The firm was founded in 2004 by Sun Microsystems co-founder Vinod Khosla and is headquartered in Menlo Park, California.
Artificial Intelligence 40%Health Care 18%Financial Services 10%Series A–C+
Portfolio sectors
Artificial Intelligence 40%Health Care 18%Financial Services 10%Software 9%Biotechnology 9%
Latest money in the portfolio
More about the fund
16 exitsnamed in 15 roundsmedian round $125M68 companies growing
Most often together with
Oxford Science Enterprises is an investment company that transforms University of Oxford science into companies tackling the world's greatest challenges. It founds, funds and builds spin-outs in life sciences, health technology, deep tech and AI, and was among the backers of Vaccitech and Oxford Nanopore. Established in 2015 as Oxford Sciences Innovation, it is based in Oxford and operates under a long-term partnership with the university.
Health Care 24%Artificial Intelligence 24%Hardware 22%Seed
Portfolio sectors
Health Care 24%Artificial Intelligence 24%Hardware 22%Biotechnology 20%Education 15%
Latest money in the portfolio
More about the fund
7 exitsnamed in 1 roundsmedian round $55M8 companies growing
Most often together with
8VC
Leads rounds · 3 in 12 mo
8VC is a technology and bio-sciences investment firm which invests in the world’s most ambitious and innovative companies.
Artificial Intelligence 27%Health Care 25%Software 23%SeedUnited States
Portfolio sectors
Artificial Intelligence 27%Health Care 25%Software 23%Financial Services 11%Biotechnology 9%
Latest money in the portfolio
More about the fund
20 exitsnamed in 5 roundsmedian round $60M56 companies growing
Most often together with
RA Capital Management is an evidence-based, multi-stage investor focused on healthcare, life sciences and planetary health. It invests across private and public markets, from company creation and early venture rounds to crossover and public equity positions in drug developers and platform companies. The firm was founded in 2004, is led by Peter Kolchinsky and is headquartered in Boston, Massachusetts.
Health Care 76%Biotechnology 36%Artificial Intelligence 6%Series A–C+
Portfolio sectors
Health Care 76%Biotechnology 36%Artificial Intelligence 6%Energy & Utilities 4%Robotics 3%
Latest money in the portfolio
More about the fund
93 exitsmedian round $61.2M55 companies growing
Most often together with
Octopus Ventures is a London venture capital firm that invests in early-stage companies with the potential to change the world. It backs founders from seed through Series B across B2B software, fintech, health and consumer sectors, and was an early investor in the property portal Zoopla. Part of the Octopus Group and founded in 2007, it is one of the largest and most active venture investors in Europe.
Artificial Intelligence 24%Health Care 19%Software 14%Seed–A
Portfolio sectors
Artificial Intelligence 24%Health Care 19%Software 14%Financial Services 11%Cybersecurity 9%
Latest money in the portfolio
More about the fund
3 exitsnamed in 3 roundsmedian round $25.5M16 companies growing
Most often together with
SOSV is the world’s most active deep tech venture capital firm investing at pre-seed, with deeply resourced locations for founders in New York, Newark, and San Francisco.
Health Care 19%Food & Beverages 15%Biotechnology 13%Seed
Portfolio sectors
Health Care 19%Food & Beverages 15%Biotechnology 13%Artificial Intelligence 9%Energy & Utilities 7%
Latest money in the portfolio
More about the fund
56 exitsmedian round $5M17 companies growing
Most often together with
Kleiner Perkins is an American venture capital firm headquartered on Sand Hill Road in Menlo Park in Silicon Valley.
Artificial Intelligence 27%Software 18%Health Care 15%Series A–C+
Portfolio sectors
Artificial Intelligence 27%Software 18%Health Care 15%Financial Services 10%Cybersecurity 10%
Latest money in the portfolio
More about the fund
119 exitsnamed in 6 roundsmedian round $160M141 companies growing
Most often together with
Future Planet Capital is an impact-led venture capital firm investing in innovation emerging from leading universities and research ecosystems. It backs companies in areas such as health, education, climate and sustainability technology, drawing on partnerships with academic institutions around the world. The firm was founded in 2013 by Douglas Hansen-Luke and is headquartered in London.
Health Care 18%Biotechnology 14%Education 10%Series A
Portfolio sectors
Health Care 18%Biotechnology 14%Education 10%Hardware 9%Science & Engineering 8%
Latest money in the portfolio
More about the fund
7 exitsmedian round $9.8M4 companies growing
Most often together with
High-Tech Gründerfonds is a German seed and early-stage venture capital investor that calls itself the most active VC investor in the country. It finances deep tech, life sciences, digital tech and industrial technology startups, typically providing the first institutional round and following on through later rounds. Founded in 2005 and based in Bonn, the fund is a public-private partnership backed by the German Federal Ministry for Economic Affairs and a group of industrial corporations.
Health Care 16%Software 13%Artificial Intelligence 11%Seed
Latest money: Arcos $5.9M · led · Sep 18
· 6 more rounds in 90 days
Portfolio sectors
Health Care 16%Software 13%Artificial Intelligence 11%Energy & Utilities 10%Hardware 8%
Latest money in the portfolio
More about the fund
137 exitsnamed in 2 roundsmedian round $6.7M25 companies growing
Most often together with
First Round is a venture capital firm that works with founders exclusively at the earliest stages of company building, often when all they have is an.
Artificial Intelligence 26%Software 19%Health Care 16%Series A–C+
Latest money: Serval $150M · Oct 29
· 6 more rounds in 90 days
Portfolio sectors
Artificial Intelligence 26%Software 19%Health Care 16%Financial Services 13%Sales & Marketing 8%
Latest money in the portfolio
More about the fund
31 exitsmedian round $50M52 companies growing
Most often together with
NEA
Leads rounds · 4 in 12 mo
NEA, or New Enterprise Associates, is one of the largest and longest-running venture capital firms in the United States. It invests at every stage from seed to growth in technology and healthcare companies, and its portfolio has included Workday, Databricks and Coursera. The firm was founded in 1977 in Baltimore by Dick Kramlich, Chuck Newhall and Frank Bonsal and is now headquartered in Menlo Park, California.
Health Care 21%Artificial Intelligence 21%Software 15%Series A–B
Latest money: Tamr $21M · Oct 14
· 5 more rounds in 90 days
Portfolio sectors
Health Care 21%Artificial Intelligence 21%Software 15%Financial Services 8%Cybersecurity 8%
Latest money in the portfolio
More about the fund
308 exitsnamed in 5 roundsmedian round $40M192 companies growing
Most often together with
Pear VC is a venture capital firm specializing in pre-seed and seed-stage investments in startups. Founded by Pejman Nozad and Mar Hershenson, the firm provides hands-on support in areas such as product development, recruiting, fundraising, and go-to-market strategy. Pear has backed companies including DoorDash, Gusto, Aurora Solar, Vanta, and Guardant Health.
Artificial Intelligence 33%Health Care 16%Software 14%Seed–B
Latest money: Wexler AI · Sep 17
· 5 more rounds in 90 days
Portfolio sectors
Artificial Intelligence 33%Health Care 16%Software 14%Financial Services 9%Professional Services 9%
Latest money in the portfolio
More about the fund
25 exitsmedian round $33M22 companies growing
Most often together with
ARCH Venture Partners is a venture capital firm providing seed and early-stage capital to companies built on breakthrough science. It focuses mainly on life sciences and biotechnology, along with physical sciences and technology, and has backed companies such as Illumina, Juno Therapeutics and Grail. The firm was founded in 1986 as a spinout of the University of Chicago and Argonne National Laboratory technology transfer effort and is based in Chicago.
Health Care 60%Biotechnology 57%Artificial Intelligence 10%Seed–B
Portfolio sectors
Health Care 60%Biotechnology 57%Artificial Intelligence 10%Science & Engineering 4%Software 3%
Latest money in the portfolio
More about the fund
37 exitsnamed in 5 roundsmedian round $92.5M30 companies growing
Most often together with
BoxGroup is an early-stage investment fund focused on technology companies, typically writing small checks at the pre-seed and seed stages. It invests across consumer, enterprise, fintech and health technology, backing founders alongside other seed and venture investors. The firm was founded by David Tisch and Adam Rothenberg around 2009 and is based in New York City.
Artificial Intelligence 30%Software 20%Financial Services 17%Series B–C+
Portfolio sectors
Artificial Intelligence 30%Software 20%Financial Services 17%Health Care 15%Commerce 9%
Latest money in the portfolio
More about the fund
10 exitsnamed in 1 roundsmedian round $100M28 companies growing
Most often together with
Cambridge Angels is a business angel network of experienced entrepreneurs and investors based in Cambridge. Its members invest their own money and expertise in early-stage technology and life sciences startups, primarily in the Cambridge area and elsewhere in the UK. The group was founded in 2001 and is closely connected to the wider Cambridge technology and university ecosystem.
Health Care 36%Artificial Intelligence 25%Biotechnology 12%Seed–A
Portfolio sectors
Health Care 36%Artificial Intelligence 25%Biotechnology 12%Hardware 8%Education 7%
Latest money in the portfolio
More about the fund
2 exitsmedian round $5.2M3 companies growing
Most often together with
F-Prime Capital is a global venture capital firm investing in life sciences, healthcare and technology. It backs companies from early to growth stages in biotechnology, healthtech and services, fintech and enterprise software, with investment teams in the US, Europe and Asia. The firm is affiliated with Fidelity and draws on a heritage of venture investing that spans more than four decades, with headquarters in Cambridge, Massachusetts.
Health Care 44%Biotechnology 18%Blockchain & Crypto 17%Series A–C+
Portfolio sectors
Health Care 44%Biotechnology 18%Blockchain & Crypto 17%Artificial Intelligence 14%Financial Services 11%
Latest money in the portfolio
More about the fund
34 exitsnamed in 2 roundsmedian round $25.7M32 companies growing
Most often together with